Explore more publications!
Aruba Health Monitor
Got News to Share?

Aruba Health Monitor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Health Monitor.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on February 19, 2026

Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
an hour ago

Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen

Indeterminate GlobeNewswire
Olema Oncology to Present at the TD Cowen 46th Annual Health Care Conference
an hour ago

Olema Oncology to Present at the TD Cowen 46th Annual Health Care Conference

Indeterminate GlobeNewswire
BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
an hour ago

BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

Indeterminate GlobeNewswire
AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results
an hour ago

AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results

Indeterminate GlobeNewswire
STRATA Skin Sciences Confirms Nasdaq Delisting
an hour ago

STRATA Skin Sciences Confirms Nasdaq Delisting

Indeterminate GlobeNewswire
Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference
an hour ago

Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference

Indeterminate GlobeNewswire
ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance
an hour ago

ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance

Indeterminate GlobeNewswire
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026
an hour ago

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026

Indeterminate GlobeNewswire
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
an hour ago

Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference

Indeterminate GlobeNewswire
Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution Agreement in Argentina
an hour ago

Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution Agreement in Argentina

Indeterminate GlobeNewswire
MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program
an hour ago

MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program

Indeterminate GlobeNewswire
Candel Therapeutics Announces Proposed $100 Million Public Offering
an hour ago

Candel Therapeutics Announces Proposed $100 Million Public Offering

Indeterminate GlobeNewswire
Spyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
an hour ago

Spyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Galapagos verwelkomt Dr. Paulo Fontoura in haar Raad van Bestuur  
an hour ago

Galapagos verwelkomt Dr. Paulo Fontoura in haar Raad van Bestuur  

Indeterminate GlobeNewswire
Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors  
an hour ago

Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors  

Indeterminate GlobeNewswire
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
an hour ago

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Indeterminate GlobeNewswire
Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
an hour ago

Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
an hour ago

Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer

Indeterminate GlobeNewswire
Allsup Veterans Appeals Responds To Record VA Claims Processing With Expert Appeals Support
3 hours ago

Allsup Veterans Appeals Responds To Record VA Claims Processing With Expert Appeals Support

Indeterminate GlobeNewswire
Where You Live Defines Justice: Allies Against Slavery Report Shows Uneven Protections for Trafficking Victims
3 hours ago

Where You Live Defines Justice: Allies Against Slavery Report Shows Uneven Protections for Trafficking Victims

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions